188 related articles for article (PubMed ID: 38474727)
1. In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients.
Yang J; Gao H; Zhang T; Fan Y; Wu Y; Zhao X; Li Y; Wu L; Zhao H; Yang L; Zhong H; Li L; Xie X; Wu Q
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474727
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
6. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.
Jinato T; Anuntakarun S; Satthawiwat N; Chuaypen N; Tangkijvanich P
Appl Microbiol Biotechnol; 2024 Dec; 108(1):34. PubMed ID: 38183473
[TBL] [Abstract][Full Text] [Related]
7. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.
Liu Q; Li F; Zhuang Y; Xu J; Wang J; Mao X; Zhang Y; Liu X
Gut Pathog; 2019; 11():1. PubMed ID: 30675188
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
9. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Yoo S; Kim JY; Lim YS; Han S; Choi J
J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
[TBL] [Abstract][Full Text] [Related]
10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
11. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
12. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
Li X; Wu S; Du Y; Yang L; Li Y; Hong B
Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
14. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post-liver transplantation and resection.
Schemmer P; Burra P; Hu RH; Hüber CM; Loinaz C; Machida K; Vogel A; Samuel D
Liver Int; 2022 Feb; 42(2):288-298. PubMed ID: 34846790
[TBL] [Abstract][Full Text] [Related]
15. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
J Virol; 2018 May; 92(10):. PubMed ID: 29491161
[TBL] [Abstract][Full Text] [Related]
16. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
17. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
20. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]